INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Reckitt Benckiser Group Plc of Class Action Lawsuit and Upcoming Deadlines - RBGLY

Core Viewpoint - A class action lawsuit has been filed against Reckitt Benckiser Group Plc, alleging securities fraud and unlawful business practices [2][4]. Group 1: Lawsuit Details - The lawsuit involves allegations against Reckitt and certain officers and directors for engaging in securities fraud or other unlawful business practices [2]. - Investors have until August 4, 2025, to request to be appointed as Lead Plaintiff if they purchased Reckitt securities during the Class Period [2]. Group 2: Financial Impact - On March 15, 2024, Reckitt's American Depositary Share (ADS) price fell by $1.87, nearly 14%, closing at $11.44 following a $60 million verdict against its Mead Johnson subsidiary for negligence related to infant formula [3][4]. - On July 29, 2024, after a similar lawsuit against Abbott Laboratories, Reckitt's ADS price dropped by $1.02, nearly 9%, closing at $10.64 [4]. Group 3: Company Background - Pomerantz LLP, the firm handling the lawsuit, is recognized for its expertise in corporate, securities, and antitrust class litigation, having a history of recovering multimillion-dollar damages for victims of securities fraud [5].